Stocks and Investing Stocks and Investing
Tue, August 24, 2021
Mon, August 23, 2021

Colin Bristow Initiated (CADL) at Strong Buy and Held Target at $9 on, Aug 23rd, 2021


Published on 2024-10-27 17:44:19 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Initiated "Candel Therapeutics, Inc." (CADL) at Strong Buy and Held Target at $9 on, Aug 23rd, 2021.

Colin, nor any peers, have made any analyst calls on CADL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources